Siemens Healthineers (OTCMKTS:SMMNY) Shares Down 0.9% – Here’s What Happened

Posted by Latisha Jones on Jun 4th, 2026

Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) shares fell 0.9% during trading on Tuesday . The stock traded as low as $19.70 and last traded at $19.7752. 137,067 shares changed hands during mid-day trading, a decline of 20% from the average session volume of 171,414 shares. The stock had previously closed at $19.95.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded Siemens Healthineers from a “hold” rating to a “strong sell” rating in a report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Get Our Latest Report on SMMNY

Siemens Healthineers Stock Down 1.9%

The firm has a fifty day moving average price of $20.73 and a 200 day moving average price of $23.42.

Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion during the quarter, compared to analyst estimates of $6.96 billion.

Siemens Healthineers Company Profile

(Get Free Report)

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.